Logo Logo Logo Logo Logo

Contact Us

  • About Bio-Me
    • About Us
    • Team
    • Career opportunities
  • Technology
    • Our PMP™ Technology
  • Products
    • Overview
    • Gut microbiome
      • Microbiome Analysis Services
      • Clinical Diagnostics and Drug Development
      • Preventive and Consumer Health
      • Our Pipeline
    • Skin microbiome
    • Vaginal microbiome
  • News

  • About Bio-Me

    • About Us
    • Team
    • Career opportunities

  • Technology

    • Our PMP™ Technology
  • Products
    • Overview

    • Gut microbiome

      • Microbiome Analysis Services
      • Clinical Diagnostics and Drug Development
      • Preventive and Consumer Health
      • Our Pipeline
    • Skin microbiome
    • Vaginal microbiome
  • News

17 Aug From facial microbiome maps to actionable skin health insights: what a new JID publication shows about PMP™ 

Posted at 12:27h in Uncategorized

A new proof-of-concept study in the Journal of Investigative Dermatology, led by DSM-Firmenich with Bio-Me as co-authoring partner, presents a 3D facial skin microbiome mapping approach using Bio-Me's PMP™ platform, revealing marked topographical differences in microbial distribution across the face....

Read More

12 Aug Bio-Me has been selected as one of the newest companies to join Nordic Mentor Network For Entrepreneurship – NOME

Posted at 10:28h in Uncategorized

Bio-Me has been selected to join the Nordic Mentor Network For Entrepreneurship (NOME), gaining access to a network of experienced life science mentors as it scales its Precision Microbiome Profiling (PMP™) platform and explores new applications in women's health and reproductive care....

Read More

07 Sep Bio-Me selected as a partner in the PREVALUNG EU program developing predictive biomarkers associated with lung cancer risk 

Posted at 08:52h in Uncategorized

The PREVALUNG EU program aims to implement cancer risk stratification tools and personalized interventions to intercept lung cancer in cardiovascular patients. Bio-Me’s Precision Microbiome Profiling (PMP™) was chosen for high-throughput gut microbiome profiling....

Read More

27 Apr Bio-Me’s technology used for identifying bacteria associated with appendicular lean mass in a Nature Communications publication

Posted at 08:57h in Uncategorized

PMP™ was used in a recent study to identify gut microbial species that are directly associated with appendicular lean mass and bone mineral density. More than 5000 fecal samples from the HUNT Biobank in Norway were analyzed with PMP™....

Read More
IBD

05 Aug Bio-Me´s PMP™ platform demonstrates its diagnostic and prognostic applicability in pediatric IBD

Posted at 10:23h in Uncategorized

PMP™ was used in a recent study to explore the gut microbiome of children with inflammatory bowel disease (IBD), symptomatic non-IBD, and healthy children. Diagnostic, Phenotype and Prognostic Indexes were constructed based on PMP™ data with very good discriminating properties....

Read More
PMP technology

10 Jun Bio-Me´s technology demonstrates its usefulness in metabolic syndrome research in a Lancet publication

Posted at 06:02h in Uncategorized

PMP™ has shown its applicability in obesity research in a study published in The Lancet. More than 5000 fecal samples from the HUNT Biobank in Norway were analyzed with PMP™....

Read More

23 Apr Bio-Me receives 2 million Euro in public funding

Posted at 07:02h in Uncategorized

Bio-Me has received 2 million Euro in grants and public support from The Research Council of Norway to develop a companion diagnostic test for immune checkpoint inhibitor cancer treatments.
...

Read More
Bio-Me footer 2
Oslo Science Park
Gaustadalléen 21
N-0349 Oslo
Norway
Tel: +47 21 09 03 02
Email: info@bio-me.com
Read Our Privacy Policy 
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with this. Please read our privacy policy for full details regarding how we manage your data.